Oviedo-Salcedo, Tatiana
Wagner, Elias http://orcid.org/0000-0002-7147-6167
Campana, Mattia
Gagsteiger, Anna
Strube, Wolfgang
Eichhorn, Peter
Louiset, Marie-Luise
Luykx, Jurjen
de Witte, Lot D. http://orcid.org/0000-0002-7235-9958
Kahn, René S.
Benros, Michael E. http://orcid.org/0000-0003-4939-9465
Falkai, Peter
Hasan, Alkomiet
Article History
Received: 10 September 2021
Revised: 18 November 2021
Accepted: 25 November 2021
First Online: 8 December 2021
Competing interests
: T. Oviedo-Salcedo, E. Wagner, M. Campana, P. Eichhorn, A. Gagsteiger, M. L. Louiset, M. Benros, J. Luykx report no conflict of interest. W. Strube was honorary speaker for Mag & More and Neurocare. L. D. de Witte has a sponsored research agreement with Alector Inc., R. S. Kahn has served or currently serves as a consultant for Alkermes, Inc., Lundbeck, Merck, Otsuka, Roche and Sunovion and has received speaker fees from Janssen-Cilag, Lundbeck, and Otsuka. P. Falkai was honorary speaker for Janssen-Cilag, AstraZeneca, Eli Lilly, Bristol Myers-Squibb, Lundbeck, Pfizer, Bayer Vital, SmithKline Beecham, Wyeth, and Essex. During the last 5 years, he was a member of the advisory boards of Janssen-Cilag, AstraZeneca, Eli Lilly, and Lundbeck. Presently, he is a member of the advisory boards of Richter Pharma, Abbot, and Otsuka. A. Hasan has received paid speakerships from Janssen, Recordati, Otsuka, and Lundbeck. He was member of Roche, Otsuka, Lundbeck, Recordati, Rovi and Janssen advisory boards.